Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
D000284:Administration, Oral; D000328:Adult; D002986:Clinical Trials as Topic; D003961:Dianhydrogalactitol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D013402:Sugar Alcohols / Q000627:therapeutic use*
D013402:Sugar Alcohols; D003961:Dianhydrogalactitol